nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipyridamole—SLC29A1—Fluorouracil—stomach cancer	0.183	0.353	CbGbCtD
Dipyridamole—ABCC5—Fluorouracil—stomach cancer	0.14	0.27	CbGbCtD
Dipyridamole—ABCC4—Fluorouracil—stomach cancer	0.0671	0.13	CbGbCtD
Dipyridamole—ABCB1—Mitomycin—stomach cancer	0.0529	0.102	CbGbCtD
Dipyridamole—ABCC4—Methotrexate—stomach cancer	0.037	0.0715	CbGbCtD
Dipyridamole—ABCB1—Irinotecan—stomach cancer	0.0136	0.0262	CbGbCtD
Dipyridamole—ABCB1—Docetaxel—stomach cancer	0.00994	0.0192	CbGbCtD
Dipyridamole—ABCB1—Doxorubicin—stomach cancer	0.00741	0.0143	CbGbCtD
Dipyridamole—ABCB1—Methotrexate—stomach cancer	0.00718	0.0139	CbGbCtD
Dipyridamole—PDE6B—hematopoietic system—stomach cancer	0.00394	0.0366	CbGeAlD
Dipyridamole—PDE11A—epithelium—stomach cancer	0.00335	0.0311	CbGeAlD
Dipyridamole—PDE7A—hematopoietic system—stomach cancer	0.00326	0.0304	CbGeAlD
Dipyridamole—PDE6B—lymphoid tissue—stomach cancer	0.00277	0.0258	CbGeAlD
Dipyridamole—PDE5A—blood vessel—stomach cancer	0.00262	0.0243	CbGeAlD
Dipyridamole—PDE6D—bone marrow—stomach cancer	0.00257	0.0239	CbGeAlD
Dipyridamole—PDE7A—lymphoid tissue—stomach cancer	0.0023	0.0214	CbGeAlD
Dipyridamole—PDE3B—hematopoietic system—stomach cancer	0.00222	0.0206	CbGeAlD
Dipyridamole—PRUNE—liver—stomach cancer	0.00215	0.02	CbGeAlD
Dipyridamole—PDE11A—endocrine gland—stomach cancer	0.0021	0.0196	CbGeAlD
Dipyridamole—PDE6H—endocrine gland—stomach cancer	0.0021	0.0196	CbGeAlD
Dipyridamole—PDE6D—liver—stomach cancer	0.00207	0.0193	CbGeAlD
Dipyridamole—PDE11A—liver—stomach cancer	0.0019	0.0176	CbGeAlD
Dipyridamole—PDE7A—endocrine gland—stomach cancer	0.00188	0.0174	CbGeAlD
Dipyridamole—PDE6G—liver—stomach cancer	0.00183	0.017	CbGeAlD
Dipyridamole—PDE1C—lymph node—stomach cancer	0.00183	0.017	CbGeAlD
Dipyridamole—PDE3B—pancreas—stomach cancer	0.00181	0.0168	CbGeAlD
Dipyridamole—PDE8A—smooth muscle tissue—stomach cancer	0.0018	0.0167	CbGeAlD
Dipyridamole—PDE1A—smooth muscle tissue—stomach cancer	0.00174	0.0162	CbGeAlD
Dipyridamole—ADA—hematopoietic system—stomach cancer	0.00168	0.0156	CbGeAlD
Dipyridamole—PDE8A—pancreas—stomach cancer	0.00166	0.0155	CbGeAlD
Dipyridamole—PDE10A—digestive system—stomach cancer	0.00166	0.0154	CbGeAlD
Dipyridamole—PRUNE—lymph node—stomach cancer	0.00165	0.0153	CbGeAlD
Dipyridamole—PDE6D—lymph node—stomach cancer	0.00159	0.0148	CbGeAlD
Dipyridamole—PDE7B—liver—stomach cancer	0.00148	0.0137	CbGeAlD
Dipyridamole—PDE3B—bone marrow—stomach cancer	0.00142	0.0132	CbGeAlD
Dipyridamole—PDE6G—lymph node—stomach cancer	0.0014	0.013	CbGeAlD
Dipyridamole—PDE5A—hematopoietic system—stomach cancer	0.00139	0.013	CbGeAlD
Dipyridamole—PDE2A—endocrine gland—stomach cancer	0.00137	0.0127	CbGeAlD
Dipyridamole—PDE1B—endocrine gland—stomach cancer	0.00136	0.0126	CbGeAlD
Dipyridamole—PDE3A—hematopoietic system—stomach cancer	0.00136	0.0126	CbGeAlD
Dipyridamole—PDE8B—endocrine gland—stomach cancer	0.00131	0.0121	CbGeAlD
Dipyridamole—PDE3B—endocrine gland—stomach cancer	0.00127	0.0119	CbGeAlD
Dipyridamole—PDE5A—epithelium—stomach cancer	0.00127	0.0118	CbGeAlD
Dipyridamole—PDE2A—liver—stomach cancer	0.00123	0.0115	CbGeAlD
Dipyridamole—PDE5A—smooth muscle tissue—stomach cancer	0.00123	0.0114	CbGeAlD
Dipyridamole—PDE3A—smooth muscle tissue—stomach cancer	0.00119	0.0111	CbGeAlD
Dipyridamole—ADA—lymphoid tissue—stomach cancer	0.00118	0.011	CbGeAlD
Dipyridamole—PDE8B—liver—stomach cancer	0.00118	0.0109	CbGeAlD
Dipyridamole—SLC29A1—hematopoietic system—stomach cancer	0.00117	0.0109	CbGeAlD
Dipyridamole—ADA—digestive system—stomach cancer	0.00117	0.0109	CbGeAlD
Dipyridamole—PDE3B—liver—stomach cancer	0.00115	0.0107	CbGeAlD
Dipyridamole—PDE1A—endocrine gland—stomach cancer	0.00114	0.0106	CbGeAlD
Dipyridamole—PDE7B—lymph node—stomach cancer	0.00113	0.0105	CbGeAlD
Dipyridamole—ADA—bone marrow—stomach cancer	0.00108	0.01	CbGeAlD
Dipyridamole—PDE8A—liver—stomach cancer	0.00106	0.00984	CbGeAlD
Dipyridamole—PDE1A—liver—stomach cancer	0.00102	0.00953	CbGeAlD
Dipyridamole—PDE5A—digestive system—stomach cancer	0.000969	0.00901	CbGeAlD
Dipyridamole—ADA—endocrine gland—stomach cancer	0.000966	0.00899	CbGeAlD
Dipyridamole—SLC29A1—pancreas—stomach cancer	0.000952	0.00886	CbGeAlD
Dipyridamole—PDE10A—lymph node—stomach cancer	0.000946	0.0088	CbGeAlD
Dipyridamole—PDE2A—lymph node—stomach cancer	0.000946	0.0088	CbGeAlD
Dipyridamole—PDE1B—lymph node—stomach cancer	0.000937	0.00872	CbGeAlD
Dipyridamole—PDE8B—lymph node—stomach cancer	0.000902	0.00839	CbGeAlD
Dipyridamole—ABCC4—hematopoietic system—stomach cancer	0.000883	0.00821	CbGeAlD
Dipyridamole—PDE3B—lymph node—stomach cancer	0.000881	0.0082	CbGeAlD
Dipyridamole—SLC29A1—lymphoid tissue—stomach cancer	0.000824	0.00766	CbGeAlD
Dipyridamole—ABCC5—bone marrow—stomach cancer	0.000817	0.0076	CbGeAlD
Dipyridamole—SLC29A1—digestive system—stomach cancer	0.000813	0.00757	CbGeAlD
Dipyridamole—PDE8A—lymph node—stomach cancer	0.000811	0.00755	CbGeAlD
Dipyridamole—PDE5A—endocrine gland—stomach cancer	0.0008	0.00745	CbGeAlD
Dipyridamole—PDE1A—lymph node—stomach cancer	0.000785	0.0073	CbGeAlD
Dipyridamole—PDE3A—endocrine gland—stomach cancer	0.000779	0.00724	CbGeAlD
Dipyridamole—SLC29A1—bone marrow—stomach cancer	0.00075	0.00697	CbGeAlD
Dipyridamole—ABCC4—pancreas—stomach cancer	0.000719	0.00669	CbGeAlD
Dipyridamole—PDE3A—liver—stomach cancer	0.000702	0.00653	CbGeAlD
Dipyridamole—SLC29A1—endocrine gland—stomach cancer	0.000672	0.00625	CbGeAlD
Dipyridamole—ADA—lymph node—stomach cancer	0.000668	0.00621	CbGeAlD
Dipyridamole—ABCC5—liver—stomach cancer	0.00066	0.00614	CbGeAlD
Dipyridamole—PDE4A—lymph node—stomach cancer	0.000651	0.00605	CbGeAlD
Dipyridamole—ABCC4—digestive system—stomach cancer	0.000614	0.00571	CbGeAlD
Dipyridamole—SLC29A1—liver—stomach cancer	0.000606	0.00564	CbGeAlD
Dipyridamole—ABCB1—blood vessel—stomach cancer	0.000577	0.00537	CbGeAlD
Dipyridamole—ABCC4—bone marrow—stomach cancer	0.000566	0.00527	CbGeAlD
Dipyridamole—PDE5A—lymph node—stomach cancer	0.000553	0.00515	CbGeAlD
Dipyridamole—PDE3A—lymph node—stomach cancer	0.000538	0.00501	CbGeAlD
Dipyridamole—ABCC4—endocrine gland—stomach cancer	0.000507	0.00472	CbGeAlD
Dipyridamole—ABCC5—lymph node—stomach cancer	0.000506	0.00471	CbGeAlD
Dipyridamole—SLC29A1—lymph node—stomach cancer	0.000465	0.00432	CbGeAlD
Dipyridamole—ABCC4—liver—stomach cancer	0.000458	0.00426	CbGeAlD
Dipyridamole—ABCC4—lymph node—stomach cancer	0.000351	0.00326	CbGeAlD
Dipyridamole—ABCB1—hematopoietic system—stomach cancer	0.000307	0.00286	CbGeAlD
Dipyridamole—ABCB1—epithelium—stomach cancer	0.000281	0.00261	CbGeAlD
Dipyridamole—ABCB1—pancreas—stomach cancer	0.00025	0.00233	CbGeAlD
Dipyridamole—ABCB1—lymphoid tissue—stomach cancer	0.000216	0.00201	CbGeAlD
Dipyridamole—ABCB1—digestive system—stomach cancer	0.000214	0.00199	CbGeAlD
Dipyridamole—ABCB1—bone marrow—stomach cancer	0.000197	0.00183	CbGeAlD
Dipyridamole—ABCB1—endocrine gland—stomach cancer	0.000177	0.00164	CbGeAlD
Dipyridamole—Dizziness—Irinotecan—stomach cancer	0.000164	0.000975	CcSEcCtD
Dipyridamole—Haemoglobin—Epirubicin—stomach cancer	0.000164	0.000972	CcSEcCtD
Dipyridamole—Shock—Capecitabine—stomach cancer	0.000163	0.000971	CcSEcCtD
Dipyridamole—Rhinitis—Epirubicin—stomach cancer	0.000163	0.00097	CcSEcCtD
Dipyridamole—Nervous system disorder—Capecitabine—stomach cancer	0.000163	0.000968	CcSEcCtD
Dipyridamole—Haemorrhage—Epirubicin—stomach cancer	0.000163	0.000968	CcSEcCtD
Dipyridamole—Hepatitis—Epirubicin—stomach cancer	0.000163	0.000968	CcSEcCtD
Dipyridamole—Diarrhoea—Fluorouracil—stomach cancer	0.000163	0.000966	CcSEcCtD
Dipyridamole—Thrombocytopenia—Capecitabine—stomach cancer	0.000163	0.000966	CcSEcCtD
Dipyridamole—Tinnitus—Methotrexate—stomach cancer	0.000162	0.000964	CcSEcCtD
Dipyridamole—Tachycardia—Capecitabine—stomach cancer	0.000162	0.000963	CcSEcCtD
Dipyridamole—Hypoaesthesia—Epirubicin—stomach cancer	0.000162	0.000963	CcSEcCtD
Dipyridamole—Pharyngitis—Epirubicin—stomach cancer	0.000162	0.00096	CcSEcCtD
Dipyridamole—Cardiac disorder—Methotrexate—stomach cancer	0.000161	0.00096	CcSEcCtD
Dipyridamole—Skin disorder—Capecitabine—stomach cancer	0.000161	0.000958	CcSEcCtD
Dipyridamole—Hyperhidrosis—Capecitabine—stomach cancer	0.00016	0.000954	CcSEcCtD
Dipyridamole—Hypotension—Docetaxel—stomach cancer	0.00016	0.000952	CcSEcCtD
Dipyridamole—ABCB1—liver—stomach cancer	0.000159	0.00148	CbGeAlD
Dipyridamole—Angiopathy—Methotrexate—stomach cancer	0.000158	0.000938	CcSEcCtD
Dipyridamole—Vomiting—Irinotecan—stomach cancer	0.000158	0.000937	CcSEcCtD
Dipyridamole—Immune system disorder—Methotrexate—stomach cancer	0.000157	0.000934	CcSEcCtD
Dipyridamole—Dizziness—Fluorouracil—stomach cancer	0.000157	0.000934	CcSEcCtD
Dipyridamole—Mediastinal disorder—Methotrexate—stomach cancer	0.000157	0.000932	CcSEcCtD
Dipyridamole—Rash—Irinotecan—stomach cancer	0.000156	0.00093	CcSEcCtD
Dipyridamole—Dermatitis—Irinotecan—stomach cancer	0.000156	0.000929	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000156	0.000928	CcSEcCtD
Dipyridamole—Chills—Methotrexate—stomach cancer	0.000156	0.000928	CcSEcCtD
Dipyridamole—Headache—Irinotecan—stomach cancer	0.000155	0.000924	CcSEcCtD
Dipyridamole—Hypotension—Capecitabine—stomach cancer	0.000155	0.000922	CcSEcCtD
Dipyridamole—Paraesthesia—Docetaxel—stomach cancer	0.000154	0.000915	CcSEcCtD
Dipyridamole—Alopecia—Methotrexate—stomach cancer	0.000154	0.000914	CcSEcCtD
Dipyridamole—Bradycardia—Doxorubicin—stomach cancer	0.000153	0.000911	CcSEcCtD
Dipyridamole—Dyspnoea—Docetaxel—stomach cancer	0.000153	0.000909	CcSEcCtD
Dipyridamole—Somnolence—Docetaxel—stomach cancer	0.000152	0.000906	CcSEcCtD
Dipyridamole—Tinnitus—Epirubicin—stomach cancer	0.000152	0.000902	CcSEcCtD
Dipyridamole—Haemoglobin—Doxorubicin—stomach cancer	0.000151	0.0009	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000151	0.000899	CcSEcCtD
Dipyridamole—Flushing—Epirubicin—stomach cancer	0.000151	0.000898	CcSEcCtD
Dipyridamole—Cardiac disorder—Epirubicin—stomach cancer	0.000151	0.000898	CcSEcCtD
Dipyridamole—Vomiting—Fluorouracil—stomach cancer	0.000151	0.000898	CcSEcCtD
Dipyridamole—Rhinitis—Doxorubicin—stomach cancer	0.000151	0.000898	CcSEcCtD
Dipyridamole—Dyspepsia—Docetaxel—stomach cancer	0.000151	0.000897	CcSEcCtD
Dipyridamole—Haemorrhage—Doxorubicin—stomach cancer	0.000151	0.000895	CcSEcCtD
Dipyridamole—Hepatitis—Doxorubicin—stomach cancer	0.000151	0.000895	CcSEcCtD
Dipyridamole—Hypoaesthesia—Doxorubicin—stomach cancer	0.00015	0.000891	CcSEcCtD
Dipyridamole—Rash—Fluorouracil—stomach cancer	0.00015	0.00089	CcSEcCtD
Dipyridamole—Dermatitis—Fluorouracil—stomach cancer	0.00015	0.000889	CcSEcCtD
Dipyridamole—Pharyngitis—Doxorubicin—stomach cancer	0.00015	0.000889	CcSEcCtD
Dipyridamole—Paraesthesia—Capecitabine—stomach cancer	0.000149	0.000886	CcSEcCtD
Dipyridamole—Headache—Fluorouracil—stomach cancer	0.000149	0.000885	CcSEcCtD
Dipyridamole—Dysgeusia—Methotrexate—stomach cancer	0.000148	0.000881	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000148	0.00088	CcSEcCtD
Dipyridamole—Dyspnoea—Capecitabine—stomach cancer	0.000148	0.00088	CcSEcCtD
Dipyridamole—Fatigue—Docetaxel—stomach cancer	0.000148	0.000879	CcSEcCtD
Dipyridamole—Angiopathy—Epirubicin—stomach cancer	0.000148	0.000878	CcSEcCtD
Dipyridamole—Nausea—Irinotecan—stomach cancer	0.000147	0.000876	CcSEcCtD
Dipyridamole—Immune system disorder—Epirubicin—stomach cancer	0.000147	0.000874	CcSEcCtD
Dipyridamole—Mediastinal disorder—Epirubicin—stomach cancer	0.000147	0.000872	CcSEcCtD
Dipyridamole—Pain—Docetaxel—stomach cancer	0.000147	0.000871	CcSEcCtD
Dipyridamole—Back pain—Methotrexate—stomach cancer	0.000146	0.000871	CcSEcCtD
Dipyridamole—Dyspepsia—Capecitabine—stomach cancer	0.000146	0.000869	CcSEcCtD
Dipyridamole—Chills—Epirubicin—stomach cancer	0.000146	0.000868	CcSEcCtD
Dipyridamole—Arrhythmia—Epirubicin—stomach cancer	0.000145	0.000864	CcSEcCtD
Dipyridamole—Alopecia—Epirubicin—stomach cancer	0.000144	0.000855	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000143	0.000852	CcSEcCtD
Dipyridamole—Fatigue—Capecitabine—stomach cancer	0.000143	0.000851	CcSEcCtD
Dipyridamole—Pain—Capecitabine—stomach cancer	0.000142	0.000844	CcSEcCtD
Dipyridamole—Feeling abnormal—Docetaxel—stomach cancer	0.000141	0.00084	CcSEcCtD
Dipyridamole—Nausea—Fluorouracil—stomach cancer	0.000141	0.000839	CcSEcCtD
Dipyridamole—Ill-defined disorder—Methotrexate—stomach cancer	0.000141	0.000835	CcSEcCtD
Dipyridamole—Tinnitus—Doxorubicin—stomach cancer	0.00014	0.000835	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Docetaxel—stomach cancer	0.00014	0.000833	CcSEcCtD
Dipyridamole—Anaemia—Methotrexate—stomach cancer	0.00014	0.000832	CcSEcCtD
Dipyridamole—Flushing—Doxorubicin—stomach cancer	0.00014	0.000831	CcSEcCtD
Dipyridamole—Cardiac disorder—Doxorubicin—stomach cancer	0.00014	0.000831	CcSEcCtD
Dipyridamole—Flatulence—Epirubicin—stomach cancer	0.00014	0.00083	CcSEcCtD
Dipyridamole—Tension—Epirubicin—stomach cancer	0.000139	0.000827	CcSEcCtD
Dipyridamole—Dysgeusia—Epirubicin—stomach cancer	0.000139	0.000825	CcSEcCtD
Dipyridamole—Nervousness—Epirubicin—stomach cancer	0.000138	0.000818	CcSEcCtD
Dipyridamole—Back pain—Epirubicin—stomach cancer	0.000137	0.000815	CcSEcCtD
Dipyridamole—Feeling abnormal—Capecitabine—stomach cancer	0.000137	0.000813	CcSEcCtD
Dipyridamole—Angiopathy—Doxorubicin—stomach cancer	0.000137	0.000812	CcSEcCtD
Dipyridamole—Malaise—Methotrexate—stomach cancer	0.000137	0.000812	CcSEcCtD
Dipyridamole—Muscle spasms—Epirubicin—stomach cancer	0.000136	0.00081	CcSEcCtD
Dipyridamole—Immune system disorder—Doxorubicin—stomach cancer	0.000136	0.000809	CcSEcCtD
Dipyridamole—Vertigo—Methotrexate—stomach cancer	0.000136	0.000809	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Capecitabine—stomach cancer	0.000136	0.000807	CcSEcCtD
Dipyridamole—Mediastinal disorder—Doxorubicin—stomach cancer	0.000136	0.000807	CcSEcCtD
Dipyridamole—Abdominal pain—Docetaxel—stomach cancer	0.000136	0.000806	CcSEcCtD
Dipyridamole—Chills—Doxorubicin—stomach cancer	0.000135	0.000803	CcSEcCtD
Dipyridamole—Arrhythmia—Doxorubicin—stomach cancer	0.000135	0.0008	CcSEcCtD
Dipyridamole—Alopecia—Doxorubicin—stomach cancer	0.000133	0.000791	CcSEcCtD
Dipyridamole—Cough—Methotrexate—stomach cancer	0.000132	0.000785	CcSEcCtD
Dipyridamole—Urticaria—Capecitabine—stomach cancer	0.000132	0.000784	CcSEcCtD
Dipyridamole—Ill-defined disorder—Epirubicin—stomach cancer	0.000131	0.000781	CcSEcCtD
Dipyridamole—Abdominal pain—Capecitabine—stomach cancer	0.000131	0.00078	CcSEcCtD
Dipyridamole—Convulsion—Methotrexate—stomach cancer	0.000131	0.00078	CcSEcCtD
Dipyridamole—Anaemia—Epirubicin—stomach cancer	0.000131	0.000778	CcSEcCtD
Dipyridamole—Flatulence—Doxorubicin—stomach cancer	0.000129	0.000768	CcSEcCtD
Dipyridamole—Myalgia—Methotrexate—stomach cancer	0.000129	0.000766	CcSEcCtD
Dipyridamole—Chest pain—Methotrexate—stomach cancer	0.000129	0.000766	CcSEcCtD
Dipyridamole—Arthralgia—Methotrexate—stomach cancer	0.000129	0.000766	CcSEcCtD
Dipyridamole—Tension—Doxorubicin—stomach cancer	0.000129	0.000765	CcSEcCtD
Dipyridamole—Dysgeusia—Doxorubicin—stomach cancer	0.000128	0.000763	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000128	0.000761	CcSEcCtD
Dipyridamole—Malaise—Epirubicin—stomach cancer	0.000128	0.00076	CcSEcCtD
Dipyridamole—Discomfort—Methotrexate—stomach cancer	0.000127	0.000757	CcSEcCtD
Dipyridamole—Nervousness—Doxorubicin—stomach cancer	0.000127	0.000757	CcSEcCtD
Dipyridamole—Vertigo—Epirubicin—stomach cancer	0.000127	0.000757	CcSEcCtD
Dipyridamole—Syncope—Epirubicin—stomach cancer	0.000127	0.000755	CcSEcCtD
Dipyridamole—Back pain—Doxorubicin—stomach cancer	0.000127	0.000754	CcSEcCtD
Dipyridamole—Hypersensitivity—Docetaxel—stomach cancer	0.000126	0.000751	CcSEcCtD
Dipyridamole—Muscle spasms—Doxorubicin—stomach cancer	0.000126	0.000749	CcSEcCtD
Dipyridamole—Palpitations—Epirubicin—stomach cancer	0.000125	0.000744	CcSEcCtD
Dipyridamole—Loss of consciousness—Epirubicin—stomach cancer	0.000125	0.00074	CcSEcCtD
Dipyridamole—Cough—Epirubicin—stomach cancer	0.000124	0.000735	CcSEcCtD
Dipyridamole—Anaphylactic shock—Methotrexate—stomach cancer	0.000124	0.000735	CcSEcCtD
Dipyridamole—Asthenia—Docetaxel—stomach cancer	0.000123	0.000731	CcSEcCtD
Dipyridamole—Convulsion—Epirubicin—stomach cancer	0.000123	0.00073	CcSEcCtD
Dipyridamole—Hypertension—Epirubicin—stomach cancer	0.000122	0.000727	CcSEcCtD
Dipyridamole—Hypersensitivity—Capecitabine—stomach cancer	0.000122	0.000727	CcSEcCtD
Dipyridamole—ABCB1—lymph node—stomach cancer	0.000122	0.00114	CbGeAlD
Dipyridamole—Ill-defined disorder—Doxorubicin—stomach cancer	0.000122	0.000723	CcSEcCtD
Dipyridamole—Pruritus—Docetaxel—stomach cancer	0.000121	0.000721	CcSEcCtD
Dipyridamole—Nervous system disorder—Methotrexate—stomach cancer	0.000121	0.00072	CcSEcCtD
Dipyridamole—Anaemia—Doxorubicin—stomach cancer	0.000121	0.00072	CcSEcCtD
Dipyridamole—Thrombocytopenia—Methotrexate—stomach cancer	0.000121	0.000719	CcSEcCtD
Dipyridamole—Myalgia—Epirubicin—stomach cancer	0.000121	0.000717	CcSEcCtD
Dipyridamole—Chest pain—Epirubicin—stomach cancer	0.000121	0.000717	CcSEcCtD
Dipyridamole—Arthralgia—Epirubicin—stomach cancer	0.000121	0.000717	CcSEcCtD
Dipyridamole—Anxiety—Epirubicin—stomach cancer	0.00012	0.000715	CcSEcCtD
Dipyridamole—Skin disorder—Methotrexate—stomach cancer	0.00012	0.000713	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.00012	0.000712	CcSEcCtD
Dipyridamole—Hyperhidrosis—Methotrexate—stomach cancer	0.000119	0.00071	CcSEcCtD
Dipyridamole—Discomfort—Epirubicin—stomach cancer	0.000119	0.000708	CcSEcCtD
Dipyridamole—Asthenia—Capecitabine—stomach cancer	0.000119	0.000708	CcSEcCtD
Dipyridamole—Malaise—Doxorubicin—stomach cancer	0.000118	0.000703	CcSEcCtD
Dipyridamole—Dry mouth—Epirubicin—stomach cancer	0.000118	0.000701	CcSEcCtD
Dipyridamole—Vertigo—Doxorubicin—stomach cancer	0.000118	0.0007	CcSEcCtD
Dipyridamole—Syncope—Doxorubicin—stomach cancer	0.000118	0.000699	CcSEcCtD
Dipyridamole—Pruritus—Capecitabine—stomach cancer	0.000117	0.000698	CcSEcCtD
Dipyridamole—Diarrhoea—Docetaxel—stomach cancer	0.000117	0.000697	CcSEcCtD
Dipyridamole—Palpitations—Doxorubicin—stomach cancer	0.000116	0.000689	CcSEcCtD
Dipyridamole—Oedema—Epirubicin—stomach cancer	0.000116	0.000687	CcSEcCtD
Dipyridamole—Anaphylactic shock—Epirubicin—stomach cancer	0.000116	0.000687	CcSEcCtD
Dipyridamole—Hypotension—Methotrexate—stomach cancer	0.000115	0.000686	CcSEcCtD
Dipyridamole—Loss of consciousness—Doxorubicin—stomach cancer	0.000115	0.000685	CcSEcCtD
Dipyridamole—Cough—Doxorubicin—stomach cancer	0.000114	0.00068	CcSEcCtD
Dipyridamole—Shock—Epirubicin—stomach cancer	0.000114	0.000676	CcSEcCtD
Dipyridamole—Convulsion—Doxorubicin—stomach cancer	0.000114	0.000675	CcSEcCtD
Dipyridamole—Diarrhoea—Capecitabine—stomach cancer	0.000114	0.000675	CcSEcCtD
Dipyridamole—Nervous system disorder—Epirubicin—stomach cancer	0.000113	0.000674	CcSEcCtD
Dipyridamole—Dizziness—Docetaxel—stomach cancer	0.000113	0.000674	CcSEcCtD
Dipyridamole—Thrombocytopenia—Epirubicin—stomach cancer	0.000113	0.000673	CcSEcCtD
Dipyridamole—Hypertension—Doxorubicin—stomach cancer	0.000113	0.000673	CcSEcCtD
Dipyridamole—Tachycardia—Epirubicin—stomach cancer	0.000113	0.000671	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000113	0.000669	CcSEcCtD
Dipyridamole—Skin disorder—Epirubicin—stomach cancer	0.000112	0.000668	CcSEcCtD
Dipyridamole—Hyperhidrosis—Epirubicin—stomach cancer	0.000112	0.000665	CcSEcCtD
Dipyridamole—Arthralgia—Doxorubicin—stomach cancer	0.000112	0.000663	CcSEcCtD
Dipyridamole—Chest pain—Doxorubicin—stomach cancer	0.000112	0.000663	CcSEcCtD
Dipyridamole—Myalgia—Doxorubicin—stomach cancer	0.000112	0.000663	CcSEcCtD
Dipyridamole—Anxiety—Doxorubicin—stomach cancer	0.000111	0.000661	CcSEcCtD
Dipyridamole—Paraesthesia—Methotrexate—stomach cancer	0.000111	0.00066	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000111	0.000659	CcSEcCtD
Dipyridamole—Discomfort—Doxorubicin—stomach cancer	0.00011	0.000656	CcSEcCtD
Dipyridamole—Dyspnoea—Methotrexate—stomach cancer	0.00011	0.000655	CcSEcCtD
Dipyridamole—Somnolence—Methotrexate—stomach cancer	0.00011	0.000653	CcSEcCtD
Dipyridamole—Dizziness—Capecitabine—stomach cancer	0.00011	0.000652	CcSEcCtD
Dipyridamole—Dry mouth—Doxorubicin—stomach cancer	0.000109	0.000649	CcSEcCtD
Dipyridamole—Vomiting—Docetaxel—stomach cancer	0.000109	0.000648	CcSEcCtD
Dipyridamole—Dyspepsia—Methotrexate—stomach cancer	0.000109	0.000647	CcSEcCtD
Dipyridamole—Rash—Docetaxel—stomach cancer	0.000108	0.000643	CcSEcCtD
Dipyridamole—Hypotension—Epirubicin—stomach cancer	0.000108	0.000642	CcSEcCtD
Dipyridamole—Dermatitis—Docetaxel—stomach cancer	0.000108	0.000642	CcSEcCtD
Dipyridamole—Headache—Docetaxel—stomach cancer	0.000107	0.000638	CcSEcCtD
Dipyridamole—Anaphylactic shock—Doxorubicin—stomach cancer	0.000107	0.000636	CcSEcCtD
Dipyridamole—Oedema—Doxorubicin—stomach cancer	0.000107	0.000636	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000107	0.000634	CcSEcCtD
Dipyridamole—Fatigue—Methotrexate—stomach cancer	0.000107	0.000633	CcSEcCtD
Dipyridamole—Pain—Methotrexate—stomach cancer	0.000106	0.000628	CcSEcCtD
Dipyridamole—Vomiting—Capecitabine—stomach cancer	0.000106	0.000627	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000105	0.000626	CcSEcCtD
Dipyridamole—Shock—Doxorubicin—stomach cancer	0.000105	0.000626	CcSEcCtD
Dipyridamole—Nervous system disorder—Doxorubicin—stomach cancer	0.000105	0.000624	CcSEcCtD
Dipyridamole—Thrombocytopenia—Doxorubicin—stomach cancer	0.000105	0.000623	CcSEcCtD
Dipyridamole—Rash—Capecitabine—stomach cancer	0.000105	0.000622	CcSEcCtD
Dipyridamole—Dermatitis—Capecitabine—stomach cancer	0.000105	0.000622	CcSEcCtD
Dipyridamole—Tachycardia—Doxorubicin—stomach cancer	0.000104	0.000621	CcSEcCtD
Dipyridamole—Headache—Capecitabine—stomach cancer	0.000104	0.000618	CcSEcCtD
Dipyridamole—Skin disorder—Doxorubicin—stomach cancer	0.000104	0.000618	CcSEcCtD
Dipyridamole—Paraesthesia—Epirubicin—stomach cancer	0.000104	0.000617	CcSEcCtD
Dipyridamole—Hyperhidrosis—Doxorubicin—stomach cancer	0.000103	0.000615	CcSEcCtD
Dipyridamole—Dyspnoea—Epirubicin—stomach cancer	0.000103	0.000613	CcSEcCtD
Dipyridamole—Somnolence—Epirubicin—stomach cancer	0.000103	0.000611	CcSEcCtD
Dipyridamole—Nausea—Docetaxel—stomach cancer	0.000102	0.000605	CcSEcCtD
Dipyridamole—Feeling abnormal—Methotrexate—stomach cancer	0.000102	0.000605	CcSEcCtD
Dipyridamole—Dyspepsia—Epirubicin—stomach cancer	0.000102	0.000605	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Methotrexate—stomach cancer	0.000101	0.000601	CcSEcCtD
Dipyridamole—Hypotension—Doxorubicin—stomach cancer	0.0001	0.000594	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Epirubicin—stomach cancer	9.99e-05	0.000593	CcSEcCtD
Dipyridamole—Fatigue—Epirubicin—stomach cancer	9.97e-05	0.000593	CcSEcCtD
Dipyridamole—Pain—Epirubicin—stomach cancer	9.89e-05	0.000588	CcSEcCtD
Dipyridamole—Nausea—Capecitabine—stomach cancer	9.86e-05	0.000586	CcSEcCtD
Dipyridamole—Urticaria—Methotrexate—stomach cancer	9.82e-05	0.000584	CcSEcCtD
Dipyridamole—Abdominal pain—Methotrexate—stomach cancer	9.77e-05	0.000581	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Doxorubicin—stomach cancer	9.75e-05	0.000579	CcSEcCtD
Dipyridamole—Paraesthesia—Doxorubicin—stomach cancer	9.61e-05	0.000571	CcSEcCtD
Dipyridamole—Dyspnoea—Doxorubicin—stomach cancer	9.54e-05	0.000567	CcSEcCtD
Dipyridamole—Feeling abnormal—Epirubicin—stomach cancer	9.53e-05	0.000566	CcSEcCtD
Dipyridamole—Somnolence—Doxorubicin—stomach cancer	9.51e-05	0.000565	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Epirubicin—stomach cancer	9.46e-05	0.000562	CcSEcCtD
Dipyridamole—Dyspepsia—Doxorubicin—stomach cancer	9.42e-05	0.00056	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Doxorubicin—stomach cancer	9.24e-05	0.000549	CcSEcCtD
Dipyridamole—Fatigue—Doxorubicin—stomach cancer	9.23e-05	0.000548	CcSEcCtD
Dipyridamole—Urticaria—Epirubicin—stomach cancer	9.19e-05	0.000546	CcSEcCtD
Dipyridamole—Pain—Doxorubicin—stomach cancer	9.15e-05	0.000544	CcSEcCtD
Dipyridamole—Abdominal pain—Epirubicin—stomach cancer	9.14e-05	0.000543	CcSEcCtD
Dipyridamole—Hypersensitivity—Methotrexate—stomach cancer	9.11e-05	0.000541	CcSEcCtD
Dipyridamole—Asthenia—Methotrexate—stomach cancer	8.87e-05	0.000527	CcSEcCtD
Dipyridamole—Feeling abnormal—Doxorubicin—stomach cancer	8.82e-05	0.000524	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Doxorubicin—stomach cancer	8.75e-05	0.00052	CcSEcCtD
Dipyridamole—Pruritus—Methotrexate—stomach cancer	8.74e-05	0.00052	CcSEcCtD
Dipyridamole—Hypersensitivity—Epirubicin—stomach cancer	8.52e-05	0.000506	CcSEcCtD
Dipyridamole—Urticaria—Doxorubicin—stomach cancer	8.5e-05	0.000505	CcSEcCtD
Dipyridamole—Abdominal pain—Doxorubicin—stomach cancer	8.46e-05	0.000503	CcSEcCtD
Dipyridamole—Diarrhoea—Methotrexate—stomach cancer	8.46e-05	0.000503	CcSEcCtD
Dipyridamole—Asthenia—Epirubicin—stomach cancer	8.3e-05	0.000493	CcSEcCtD
Dipyridamole—Pruritus—Epirubicin—stomach cancer	8.18e-05	0.000486	CcSEcCtD
Dipyridamole—Dizziness—Methotrexate—stomach cancer	8.17e-05	0.000486	CcSEcCtD
Dipyridamole—Diarrhoea—Epirubicin—stomach cancer	7.91e-05	0.00047	CcSEcCtD
Dipyridamole—Hypersensitivity—Doxorubicin—stomach cancer	7.88e-05	0.000469	CcSEcCtD
Dipyridamole—Vomiting—Methotrexate—stomach cancer	7.86e-05	0.000467	CcSEcCtD
Dipyridamole—Rash—Methotrexate—stomach cancer	7.79e-05	0.000463	CcSEcCtD
Dipyridamole—Dermatitis—Methotrexate—stomach cancer	7.79e-05	0.000463	CcSEcCtD
Dipyridamole—Headache—Methotrexate—stomach cancer	7.74e-05	0.00046	CcSEcCtD
Dipyridamole—Asthenia—Doxorubicin—stomach cancer	7.68e-05	0.000456	CcSEcCtD
Dipyridamole—Dizziness—Epirubicin—stomach cancer	7.65e-05	0.000455	CcSEcCtD
Dipyridamole—Pruritus—Doxorubicin—stomach cancer	7.57e-05	0.00045	CcSEcCtD
Dipyridamole—Vomiting—Epirubicin—stomach cancer	7.35e-05	0.000437	CcSEcCtD
Dipyridamole—Nausea—Methotrexate—stomach cancer	7.34e-05	0.000436	CcSEcCtD
Dipyridamole—Diarrhoea—Doxorubicin—stomach cancer	7.32e-05	0.000435	CcSEcCtD
Dipyridamole—Rash—Epirubicin—stomach cancer	7.29e-05	0.000433	CcSEcCtD
Dipyridamole—Dermatitis—Epirubicin—stomach cancer	7.29e-05	0.000433	CcSEcCtD
Dipyridamole—Headache—Epirubicin—stomach cancer	7.25e-05	0.000431	CcSEcCtD
Dipyridamole—Dizziness—Doxorubicin—stomach cancer	7.08e-05	0.000421	CcSEcCtD
Dipyridamole—Nausea—Epirubicin—stomach cancer	6.87e-05	0.000408	CcSEcCtD
Dipyridamole—Vomiting—Doxorubicin—stomach cancer	6.8e-05	0.000404	CcSEcCtD
Dipyridamole—Rash—Doxorubicin—stomach cancer	6.75e-05	0.000401	CcSEcCtD
Dipyridamole—Dermatitis—Doxorubicin—stomach cancer	6.74e-05	0.000401	CcSEcCtD
Dipyridamole—Headache—Doxorubicin—stomach cancer	6.7e-05	0.000398	CcSEcCtD
Dipyridamole—Nausea—Doxorubicin—stomach cancer	6.36e-05	0.000378	CcSEcCtD
Dipyridamole—PDE1C—Signaling Pathways—KRAS—stomach cancer	7.6e-06	3.68e-05	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—PIK3CA—stomach cancer	7.58e-06	3.67e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IL6ST—stomach cancer	7.58e-06	3.67e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	7.58e-06	3.67e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	7.58e-06	3.67e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—SERPINE1—stomach cancer	7.57e-06	3.67e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—CDKN1A—stomach cancer	7.55e-06	3.66e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—CDKN1A—stomach cancer	7.55e-06	3.66e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—PIK3CA—stomach cancer	7.53e-06	3.65e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—PIK3CA—stomach cancer	7.53e-06	3.65e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—KRAS—stomach cancer	7.5e-06	3.63e-05	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—HRAS—stomach cancer	7.5e-06	3.63e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—KRAS—stomach cancer	7.5e-06	3.63e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—CDKN1B—stomach cancer	7.48e-06	3.62e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CDKN1A—stomach cancer	7.48e-06	3.62e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IL6R—stomach cancer	7.4e-06	3.58e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—SREBF2—stomach cancer	7.39e-06	3.58e-05	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—PIK3CA—stomach cancer	7.38e-06	3.57e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—SERPINE1—stomach cancer	7.37e-06	3.57e-05	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—TP53—stomach cancer	7.36e-06	3.57e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—PIK3CA—stomach cancer	7.36e-06	3.56e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—KRAS—stomach cancer	7.31e-06	3.54e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—RHOA—stomach cancer	7.31e-06	3.54e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—RORA—stomach cancer	7.3e-06	3.54e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—MAPK8—stomach cancer	7.3e-06	3.54e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—STAT3—stomach cancer	7.3e-06	3.53e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—KRAS—stomach cancer	7.29e-06	3.53e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—TP53—stomach cancer	7.29e-06	3.53e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—TP53—stomach cancer	7.29e-06	3.53e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—APC—stomach cancer	7.29e-06	3.53e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—MAPK1—stomach cancer	7.26e-06	3.52e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—EGFR—stomach cancer	7.26e-06	3.52e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—PTGS2—stomach cancer	7.23e-06	3.5e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—NOS3—stomach cancer	7.23e-06	3.5e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—ERBB2—stomach cancer	7.22e-06	3.5e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	7.22e-06	3.5e-05	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—IL6—stomach cancer	7.18e-06	3.48e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	7.16e-06	3.47e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—RHOA—stomach cancer	7.11e-06	3.44e-05	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—HRAS—stomach cancer	7.04e-06	3.41e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—NOS3—stomach cancer	7.03e-06	3.41e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—PIK3CA—stomach cancer	6.99e-06	3.38e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—MAPK3—stomach cancer	6.98e-06	3.38e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—MAPK3—stomach cancer	6.97e-06	3.38e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—HRAS—stomach cancer	6.97e-06	3.38e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—HRAS—stomach cancer	6.97e-06	3.38e-05	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—PIK3CA—stomach cancer	6.94e-06	3.36e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—SERPINE1—stomach cancer	6.93e-06	3.36e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—CDKN1A—stomach cancer	6.91e-06	3.34e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—PIK3CA—stomach cancer	6.89e-06	3.34e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—PIK3CA—stomach cancer	6.89e-06	3.34e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—KRAS—stomach cancer	6.86e-06	3.32e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CXCL8—stomach cancer	6.85e-06	3.32e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ALDOB—stomach cancer	6.85e-06	3.32e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—HRAS—stomach cancer	6.81e-06	3.3e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IL6R—stomach cancer	6.77e-06	3.28e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—ERBB2—stomach cancer	6.76e-06	3.28e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—TP53—stomach cancer	6.76e-06	3.27e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—STAT3—stomach cancer	6.74e-06	3.26e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—STAT3—stomach cancer	6.74e-06	3.26e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—PIK3CA—stomach cancer	6.72e-06	3.25e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—PIK3CA—stomach cancer	6.7e-06	3.25e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CDKN1B—stomach cancer	6.69e-06	3.24e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—RHOA—stomach cancer	6.68e-06	3.24e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—STAT3—stomach cancer	6.67e-06	3.23e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—IL6—stomach cancer	6.67e-06	3.23e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—IL6—stomach cancer	6.67e-06	3.23e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—TP53—stomach cancer	6.67e-06	3.23e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—MAPK1—stomach cancer	6.64e-06	3.22e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—EGFR—stomach cancer	6.64e-06	3.22e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—MAPK1—stomach cancer	6.63e-06	3.21e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—EGFR—stomach cancer	6.63e-06	3.21e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—NOS3—stomach cancer	6.61e-06	3.2e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—ERBB2—stomach cancer	6.58e-06	3.19e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	6.58e-06	3.19e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—IL6—stomach cancer	6.51e-06	3.16e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—TP53—stomach cancer	6.5e-06	3.15e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—HRAS—stomach cancer	6.46e-06	3.13e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—MAPK3—stomach cancer	6.44e-06	3.12e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—MAPK3—stomach cancer	6.44e-06	3.12e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CXCL8—stomach cancer	6.41e-06	3.11e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CCND1—stomach cancer	6.38e-06	3.09e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—MAPK3—stomach cancer	6.38e-06	3.09e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—HRAS—stomach cancer	6.38e-06	3.09e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—HRAS—stomach cancer	6.37e-06	3.09e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—JUN—stomach cancer	6.37e-06	3.08e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ALOX5—stomach cancer	6.36e-06	3.08e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	6.36e-06	3.08e-05	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—PIK3CA—stomach cancer	6.34e-06	3.07e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—SERPINE1—stomach cancer	6.34e-06	3.07e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—PIK3CA—stomach cancer	6.3e-06	3.05e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—KRAS—stomach cancer	6.27e-06	3.04e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—KRAS—stomach cancer	6.26e-06	3.03e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CDKN1B—stomach cancer	6.26e-06	3.03e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—DPYD—stomach cancer	6.26e-06	3.03e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—MYC—stomach cancer	6.26e-06	3.03e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—MYC—stomach cancer	6.26e-06	3.03e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CXCL8—stomach cancer	6.24e-06	3.02e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—HRAS—stomach cancer	6.21e-06	3.01e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—HRAS—stomach cancer	6.2e-06	3e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MMP9—stomach cancer	6.2e-06	3e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—ERBB2—stomach cancer	6.19e-06	3e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—IL6—stomach cancer	6.19e-06	3e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CDKN1A—stomach cancer	6.17e-06	2.99e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—STAT3—stomach cancer	6.16e-06	2.98e-05	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—PIK3CA—stomach cancer	6.13e-06	2.97e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—MAPK1—stomach cancer	6.12e-06	2.97e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—MAPK1—stomach cancer	6.12e-06	2.97e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	6.12e-06	2.97e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—EGFR—stomach cancer	6.12e-06	2.97e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—EGFR—stomach cancer	6.12e-06	2.97e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—RHOA—stomach cancer	6.11e-06	2.96e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—IL6—stomach cancer	6.1e-06	2.96e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—IL6—stomach cancer	6.1e-06	2.95e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CDKN1B—stomach cancer	6.09e-06	2.95e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—MAPK1—stomach cancer	6.07e-06	2.94e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—EGFR—stomach cancer	6.07e-06	2.94e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—NOS3—stomach cancer	6.05e-06	2.93e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MAPK8—stomach cancer	6.03e-06	2.92e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CCND1—stomach cancer	5.98e-06	2.89e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—JUN—stomach cancer	5.96e-06	2.89e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—IL6—stomach cancer	5.95e-06	2.88e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—IL6—stomach cancer	5.93e-06	2.87e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—MAPK3—stomach cancer	5.89e-06	2.85e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CXCL8—stomach cancer	5.87e-06	2.84e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—HRAS—stomach cancer	5.83e-06	2.82e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CCND1—stomach cancer	5.81e-06	2.82e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MMP9—stomach cancer	5.8e-06	2.81e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—JUN—stomach cancer	5.8e-06	2.81e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—KRAS—stomach cancer	5.78e-06	2.8e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—KRAS—stomach cancer	5.78e-06	2.8e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CDKN1A—stomach cancer	5.78e-06	2.8e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—PIK3CA—stomach cancer	5.76e-06	2.79e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—PIK3CA—stomach cancer	5.76e-06	2.79e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—KRAS—stomach cancer	5.73e-06	2.78e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CDKN1B—stomach cancer	5.73e-06	2.77e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—MYC—stomach cancer	5.73e-06	2.77e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—ERBB2—stomach cancer	5.66e-06	2.74e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MMP9—stomach cancer	5.64e-06	2.73e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MAPK8—stomach cancer	5.64e-06	2.73e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CDKN1A—stomach cancer	5.62e-06	2.72e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—MAPK1—stomach cancer	5.6e-06	2.71e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—EGFR—stomach cancer	5.6e-06	2.71e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—IL6—stomach cancer	5.58e-06	2.7e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—VEGFA—stomach cancer	5.56e-06	2.7e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GSTT1—stomach cancer	5.54e-06	2.68e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—STAT3—stomach cancer	5.51e-06	2.67e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MAPK8—stomach cancer	5.49e-06	2.66e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CYP2A6—stomach cancer	5.47e-06	2.65e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CCND1—stomach cancer	5.47e-06	2.65e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—JUN—stomach cancer	5.45e-06	2.64e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CXCL8—stomach cancer	5.37e-06	2.6e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—HRAS—stomach cancer	5.33e-06	2.58e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—HRAS—stomach cancer	5.33e-06	2.58e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—AKR1C3—stomach cancer	5.32e-06	2.58e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—PIK3CA—stomach cancer	5.31e-06	2.57e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—PIK3CA—stomach cancer	5.31e-06	2.57e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MMP9—stomach cancer	5.31e-06	2.57e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—KRAS—stomach cancer	5.29e-06	2.56e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CDKN1A—stomach cancer	5.29e-06	2.56e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—PIK3CA—stomach cancer	5.26e-06	2.55e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MAPK3—stomach cancer	5.26e-06	2.55e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CDKN1B—stomach cancer	5.24e-06	2.54e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—VEGFA—stomach cancer	5.21e-06	2.52e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ENO1—stomach cancer	5.19e-06	2.51e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MAPK8—stomach cancer	5.16e-06	2.5e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—STAT3—stomach cancer	5.16e-06	2.5e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MYC—stomach cancer	5.12e-06	2.48e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—IL6—stomach cancer	5.1e-06	2.47e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IL6—stomach cancer	5.1e-06	2.47e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—VEGFA—stomach cancer	5.07e-06	2.45e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—STAT3—stomach cancer	5.02e-06	2.43e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MAPK1—stomach cancer	5.01e-06	2.43e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—EGFR—stomach cancer	5.01e-06	2.43e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CCND1—stomach cancer	5e-06	2.42e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—JUN—stomach cancer	4.99e-06	2.42e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MAPK3—stomach cancer	4.93e-06	2.39e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—HRAS—stomach cancer	4.92e-06	2.38e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—HRAS—stomach cancer	4.92e-06	2.38e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—HRAS—stomach cancer	4.87e-06	2.36e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—PIK3CA—stomach cancer	4.86e-06	2.35e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MMP9—stomach cancer	4.85e-06	2.35e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	4.85e-06	2.35e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CDKN1A—stomach cancer	4.84e-06	2.34e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MAPK3—stomach cancer	4.79e-06	2.32e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MYC—stomach cancer	4.79e-06	2.32e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—VEGFA—stomach cancer	4.76e-06	2.31e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—KRAS—stomach cancer	4.73e-06	2.29e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MAPK8—stomach cancer	4.72e-06	2.29e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—STAT3—stomach cancer	4.72e-06	2.29e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—IL6—stomach cancer	4.71e-06	2.28e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—IL6—stomach cancer	4.71e-06	2.28e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MAPK1—stomach cancer	4.69e-06	2.27e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—EGFR—stomach cancer	4.69e-06	2.27e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MYC—stomach cancer	4.66e-06	2.26e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IL6—stomach cancer	4.66e-06	2.26e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CD44—stomach cancer	4.6e-06	2.23e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MAPK1—stomach cancer	4.56e-06	2.21e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—EGFR—stomach cancer	4.56e-06	2.21e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MAPK3—stomach cancer	4.51e-06	2.18e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—HRAS—stomach cancer	4.5e-06	2.18e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—PIK3CA—stomach cancer	4.45e-06	2.16e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—KRAS—stomach cancer	4.43e-06	2.15e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MYC—stomach cancer	4.38e-06	2.12e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—VEGFA—stomach cancer	4.36e-06	2.11e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—PIK3CA—stomach cancer	4.35e-06	2.1e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—STAT3—stomach cancer	4.31e-06	2.09e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—KRAS—stomach cancer	4.31e-06	2.09e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—IL6—stomach cancer	4.3e-06	2.08e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MAPK1—stomach cancer	4.29e-06	2.08e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—EGFR—stomach cancer	4.29e-06	2.08e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—TP53—stomach cancer	4.2e-06	2.04e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MAPK3—stomach cancer	4.12e-06	2e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—PIK3CA—stomach cancer	4.07e-06	1.97e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—KRAS—stomach cancer	4.05e-06	1.96e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—HRAS—stomach cancer	4.02e-06	1.95e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MYC—stomach cancer	4.01e-06	1.94e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—PIK3CA—stomach cancer	3.96e-06	1.92e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TP53—stomach cancer	3.94e-06	1.91e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MAPK1—stomach cancer	3.92e-06	1.9e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—EGFR—stomach cancer	3.92e-06	1.9e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PPP2R1A—stomach cancer	3.91e-06	1.89e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IL6—stomach cancer	3.85e-06	1.86e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GSTP1—stomach cancer	3.84e-06	1.86e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TP53—stomach cancer	3.83e-06	1.85e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—HMOX1—stomach cancer	3.78e-06	1.83e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—HRAS—stomach cancer	3.76e-06	1.82e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—PIK3CA—stomach cancer	3.72e-06	1.8e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—KRAS—stomach cancer	3.7e-06	1.79e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—HRAS—stomach cancer	3.66e-06	1.77e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IL6—stomach cancer	3.6e-06	1.75e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TP53—stomach cancer	3.6e-06	1.74e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—TYMS—stomach cancer	3.57e-06	1.73e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GSTM1—stomach cancer	3.53e-06	1.71e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IL6—stomach cancer	3.5e-06	1.7e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—HRAS—stomach cancer	3.44e-06	1.67e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PIK3CA—stomach cancer	3.4e-06	1.65e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ERCC2—stomach cancer	3.32e-06	1.61e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IL6—stomach cancer	3.3e-06	1.6e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TP53—stomach cancer	3.29e-06	1.59e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—HRAS—stomach cancer	3.15e-06	1.53e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—MTHFR—stomach cancer	3.12e-06	1.51e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IL6—stomach cancer	3.01e-06	1.46e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CAV1—stomach cancer	2.87e-06	1.39e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—APOA1—stomach cancer	2.87e-06	1.39e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PPARG—stomach cancer	2.53e-06	1.22e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ALB—stomach cancer	2.27e-06	1.1e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—NOS3—stomach cancer	2.17e-06	1.05e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PTGS2—stomach cancer	1.99e-06	9.63e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PIK3CA—stomach cancer	1.22e-06	5.92e-06	CbGpPWpGaD
